Inthera Bioscience intherabio.com

Inthera Bioscience, founded in 2013, employs a proprietary technology platform to rationally design protein-protein interaction inhibitors. The company has discovered disruptors of hypoxia-inducible signaling for the treatment of solid tumors and targeted agents against HPV- associated cancer, which are in pre-clinical development. Inthera Bioscience is a biopharmaceutical company focused on developing inhibitors of intracellular protein-protein interactions employing a proprietary technology pl...Show all

Inthera Bioscience, founded in 2013, employs a proprietary technology platform to rationally design protein-protein interaction inhibitors. The company has discovered disruptors of hypoxia-inducible signaling for the treatment of solid tumors and tar...Show all

Company (Alive / Active)

All investors data 5 Investors

• Aglaia Oncology Funds
• Erfindungs Verwertung
• Merck Ventures
• Novo Holdings
• Novo Seeds

Board Members

Competitors

Patents